In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer

Breast cancer is the most frequently diagnosed cancer in women and the second most common cancer overall, with nearly [Formula: see text] million new cases worldwide every year. Breast cancer patients need accurate tools for early diagnosis and to improve treatment. Biomarkers are increasingly used...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazo, Claudia, Orue-Etxebarria, Estibaliz, Zabalza, Ignacio, Vivanco, Maria d. M., Kypta, Robert M., Beristain, Andoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316458/
https://www.ncbi.nlm.nih.gov/pubmed/30558303
http://dx.doi.org/10.3390/cancers10120517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316458/
https://www.ncbi.nlm.nih.gov/pubmed/30558303
http://dx.doi.org/10.3390/cancers10120517

Ejemplares similares